Cargando…
Lysosomal Targeting of β‐Cyclodextrin
β‐Cyclodextrin (β‐CD) and derivatives are approved therapeutics in >30 clinical settings. β‐CDs have also shown promise as therapeutics for treatment of some lysosomal storage disorders, such as Niemann‐Pick disease type C, and other disease states which involve metabolite accumulation in the lys...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100462/ https://www.ncbi.nlm.nih.gov/pubmed/36265126 http://dx.doi.org/10.1002/chem.202203252 |